WIN

WIN was created to accelerate the pace and reduce the cost of translating novel cancer treatments to the bedside by developing and applying, through worldwide clinical trials and research projects, the most promising advances in genomic-based cancer research. WIN aims to initiate research projects each year in a global consortium guided by an independent scientific advisory board... WIN is currently planning innovative global clinical trials that represent the next generation of studies focused on lung cancer... The WIN Consortium is organized in the following groups who collectively work together to achieve WIN's common goals

Also known as: The WIN Consortium, Win Consortium

Primary location: Larue France